1. Home
  2. PCLA vs AIMD Comparison

PCLA vs AIMD Comparison

Compare PCLA & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCLA
  • AIMD
  • Stock Information
  • Founded
  • PCLA 2008
  • AIMD 1984
  • Country
  • PCLA Japan
  • AIMD United States
  • Employees
  • PCLA N/A
  • AIMD N/A
  • Industry
  • PCLA Building Products
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCLA Consumer Discretionary
  • AIMD Health Care
  • Exchange
  • PCLA Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • PCLA 18.6M
  • AIMD 16.9M
  • IPO Year
  • PCLA 2025
  • AIMD N/A
  • Fundamental
  • Price
  • PCLA $0.42
  • AIMD $3.62
  • Analyst Decision
  • PCLA
  • AIMD
  • Analyst Count
  • PCLA 0
  • AIMD 0
  • Target Price
  • PCLA N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • PCLA 130.8K
  • AIMD 64.2K
  • Earning Date
  • PCLA 01-01-0001
  • AIMD 11-14-2025
  • Dividend Yield
  • PCLA N/A
  • AIMD N/A
  • EPS Growth
  • PCLA N/A
  • AIMD N/A
  • EPS
  • PCLA N/A
  • AIMD N/A
  • Revenue
  • PCLA $5,065,197.00
  • AIMD $110,870.00
  • Revenue This Year
  • PCLA N/A
  • AIMD N/A
  • Revenue Next Year
  • PCLA N/A
  • AIMD N/A
  • P/E Ratio
  • PCLA N/A
  • AIMD N/A
  • Revenue Growth
  • PCLA 5.26
  • AIMD 70.25
  • 52 Week Low
  • PCLA $0.37
  • AIMD $2.00
  • 52 Week High
  • PCLA $9.80
  • AIMD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • PCLA 40.88
  • AIMD 46.66
  • Support Level
  • PCLA $0.41
  • AIMD $3.39
  • Resistance Level
  • PCLA $0.45
  • AIMD $3.75
  • Average True Range (ATR)
  • PCLA 0.03
  • AIMD 0.24
  • MACD
  • PCLA 0.00
  • AIMD -0.06
  • Stochastic Oscillator
  • PCLA 24.11
  • AIMD 21.90

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: